Need professional-grade analysis? Visit stockanalysis.com
$13.87B
N/A
1,189
N/A
Ascendis Pharma AS (ASND) trades on United States in USD. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at $244.48, up 0.63% from the previous close.
Over the past year, ASND has traded between a low of $151.25 and a high of $249.84. The stock has gained 53.6% over this period. It is currently 61.6% above its 52-week low.
Ascendis Pharma AS has a market capitalization of $13.87B.
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
Side-by-side comparison against top Healthcare peers.